• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Rab GTPase-binding effector protein 2 (RABEP2)

ACP10984

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP10984 Target NameRABEP2
FormLyophilized powderExpression SystemCustom Production. Please inquire and provide the desire expression system.
Expression Range2-569Protein LengthFull Length of Mature Protein
Purity>85% (SDS-PAGE)Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ9H5N1
Background Information
  • Uniprot Id

    Q9H5N1

  • Target Species

    Human

  • Target Name

    RABEP2

  • Target Full Name

    Rab GTPase-binding effector protein 2

  • Target Function

    Plays a role in membrane trafficking and in homotypic early endosome fusion. Participates in arteriogenesis by regulating vascular endothelial growth factor receptor 2/VEGFR2 cell surface expression and endosomal trafficking. By interacting with SDCCAG8, localizes to centrosomes and plays a critical role in ciliogenesis.

  • Target Subcellular Location

    Cytoplasm. Early endosome. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome. Cytoplasm, cytoskeleton, cilium basal body.

  • Target Protein Families

    Rabaptin family

  • Target Synonyms

    FLJ23282; FRA; Rab GTPase binding effector protein 2; Rab GTPase-binding effector protein 2; Rabaptin 5 beta; Rabaptin RAB GTPase binding effector protein 2; Rabaptin-5beta; RABE2_HUMAN; RABEP 2; RABEP2; RABPT5B

Inquire Recombinant Human Rab GTPase-binding effector protein 2 (RABEP2) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification